Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)NCT05494788CRDLPhase 2Completed2024-06-15Actual
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary DiseaseNCT05496374Spero TherapeuticsPhase 2Completed2024-10-08Actual
Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria FlaresNCT05496465SPRYPhase 2Completed2024-02-29Actual
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)NCT05500222MDGLPhase 3Active not recruiting2026-12Estimated
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)NCT05501886CELCPhase 3Active not recruiting2026-06-30Estimated
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)NCT05506943Compass TherapeuticsPhase 2, Phase 3Active not recruiting2027-08-31Estimated
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1NCT05507203ABVXPhase 3Completed2025-06-24Actual
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2NCT05507216ABVXPhase 3Completed2025-06-24Actual
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)NCT05509023QTTBPhase 2Active not recruiting2024-12Estimated
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic ArthritisNCT05511519ACRSPhase 2Terminated2023-12-06Actual
A Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerNCT05513742Compass TherapeuticsPhase 2Completed2025-05-15Actual
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich AtaxiaNCT05515536PTC TherapeuticsPhase 3Active not recruiting2027-12-31Estimated
Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant EpilepsyNCT05518578SUPNPhase 2Recruiting2027-12-31Estimated
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineNCT05519839NovavaxPhase 2Completed2023-07-25Actual
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeNCT05521438Quoin PharmaceuticalsPhase 2, Phase 3Active not recruiting2025-12-30Actual
An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseNCT05522387INMBPhase 2Terminated2024-06-05Actual
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum DisorderNCT05523895ACADPhase 2, Phase 3Completed2024-09-27Actual
Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810NCT05526066Arcturus Therapeutics, Inc.Phase 2Terminated2024-10-31Actual
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced MelanomaNCT05529316AGENPhase 2Active not recruiting2028-02Estimated
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseNCT05531656Cognition TherapeuticsPhase 2Active not recruiting2027-05-31Estimated
ABTECT - MaintenanceNCT05535946ABVXPhase 3Active not recruiting2026-04-28Actual
Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease EventsNCT05537571SLNPhase 2Completed2024-01-11Actual
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy VolunteersNCT05539872AMPHPhase 2, Phase 3Completed2023-01-29Actual
A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)NCT05540860EWTXPhase 2Active not recruiting2027-01Estimated
Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia SubjectsNCT05541939VOGXPhase 2Completed2023-02-17Actual
Clinical Trial on Agitation in Alzheimer's DementiaNCT05543681IGC Pharma, LLCPhase 2Recruiting2026-08Estimated
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary HyperparathyroidismNCT05543928OPKPhase 3Terminated2024-06-19Actual
A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaNCT05548296Acrivon TherapeuticsPhase 2Recruiting2027-05-30Estimated
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)NCT05549297Immunocore LtdPhase 3Recruiting2028-03Estimated
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryNCT05549505ARVNPhase 2Completed2024-07-13Actual

ABTECT - Maintenance

ABVXActive not recruitingPrimary completion: 2026-04-28 · Actual
Trial details
Registry ID
NCT05535946
Phase
Phase 3

Primary completion marks the end of data collection for the main study measures, not a results publication date.